These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 2445044)

  • 1. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE
    Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.
    Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Abbink JJ; Strack van Schijndel RJ; Felt-Bersma RJ; Thijs LG; Hack CE
    Blood; 1988 Dec; 72(6):1841-8. PubMed ID: 3264190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
    Kaplan AP; Gruber B; Harpel PC
    Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prekallikrein activation and kallikrein inactivation in human plasma.
    van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
    Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
    [No Abstract]   [Full Text] [Related]  

  • 8. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of contact activation by sulfatides.
    Tans G; Griffin JH
    Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
    van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
    Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
    Dors DM; Nuijens JH; Huijbregts CC; Hack CE
    Thromb Haemost; 1992 Jun; 67(6):644-8. PubMed ID: 1509403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylprednisolone induces activation of the contact system in a dose-dependent manner. An in vitro study.
    Roeise O; Nuijens JH; Hack CE; Bouma BN; Stadaas JO; Aasen AO
    Thromb Res; 1990 Mar; 57(6):877-88. PubMed ID: 2382256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma.
    Lewin MF; Kaplan AP; Harpel PC
    J Biol Chem; 1983 May; 258(10):6415-21. PubMed ID: 6343376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
    Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Meijers JC; Bouma BN; Hack CE
    J Biol Chem; 1989 Aug; 264(22):12941-9. PubMed ID: 2473984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Western blot analyses of prekallikrein and its activation products in human plasma.
    Veloso D; Colman RW
    Thromb Haemost; 1991 Apr; 65(4):382-8. PubMed ID: 1711719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.